Patent Yard Sign in
Canadian application, no grantCanada

New pharmaceutical compounds

CA 2467166 A1 · Owner: Gynther, Jukka · Inventors: Gynther, Jukka; Savolainen, Jouko; Huuskonen, Juhani

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Compounds of formula (I), wherein E, G T, Rd, Re, and Rf are as defined in , claims release levodopa and a COMT inhibitor so that they can be used for the treatment of diseases or conditions, wherein levodopa and inhibition of COMT are indicated to be useful.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed November 18, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 18, 2022.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 18, 2024.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledNovember 18, 2002
GrantedNo grant recorded
Term endedNovember 18, 2022
Patent numberCA 2467166 A1
Classification (IPC)C07C255/44 +2 more

Timeline

Timeline From CIPO dates

2003200520072009201120132015201720192021Application filedNov 18, 2002Term endedNov 18, 2022

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.